FDA NDC Directory · JSON-LD · Markdown

Carafate

NDC 58914-170 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameSucralfate
Labeler / ManufacturerAllergan, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA019183
Dosage form / routeSUSPENSION · ORAL
Active ingredientsSUCRALFATE (1 g/10mL)
Marketing started19931216
Package count2

External sources

Source: openFDA. Public-domain (CC0).